Alpha-4 integrin receptor antagonist
gastro-intestinaal middel
immunosuppressivum
monoklonaal antilichaam
|
|
|
|
natalizumab (substantie)
natalizumab
Natalizumab
Id
414805007
Status
Primitive
Has disposition
alfa-4-integrinereceptorantagonist
Has disposition
immunomodulator